Acushnet Holdings

Acushnet Holdings is a holding company. Through its subsidiaries, the company designs, develops, manufactures, and distributes golf products. The company's products include golf balls, golf clubs, wedges and putters, golf shoes, golf gloves, golf gear and golf and ski outerwear and apparel. The company is also engaged in custom imprinted golf balls. This includes printing corporate logos, tournament logos, country club or resort logos, and personalization on Titleist and Pinnacle golf balls. The company designs, assembles and sells golf clubs (drivers, fairways, hybrids and irons) under the Titleist brand, wedges under the Vokey Design brand and putters under the Scotty Cameron brand.
  • TickerGOLF
  • ISINUS0050981085
  • ExchangeNew York Stock Exchange
  • SectorLeisure Goods
  • CountryUnited States
Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Acushnet Holdings Corp: 1 director sold

A director at Acushnet Holdings Corp sold 20,000 shares at 35.640USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names ...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Signs Point To Healthy Pullback Opportunity The risk of a correction due to a “second wave” of infections has given way to optimism over increased monetary and fiscal stimulus and a potential COVID-19 steroid treatment. For now we view recent weakness as a countertrend move that helped correct the overbought conditions we noted last week. As long as the S&P 500 is above the 2940-2980 support zone we remain bullish and view this as a buyable pullback. · Major Indexes Remain Above Key Support Levels; Small- & Mid-Caps Still Outperforming. The S&P 500 has held above the big support...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Bulls Remain In Control It is hard to believe the market is within reach of its prior highs considering everything that has transpired this year: rioting/looting, a global pandemic, historic unemployment levels, and rising US-China tensions. The market is looking past these concerns in favor of the positives, namely: historic fiscal and monetary support, reopening the economy/flattening the curve, COVID-19 vaccine/treatment hopes, and low rates. As long as the breakouts that we highlighted last week (and again below) continue to hold, a bullish stance is appropriate. Below we highlight reason...

Shelley Moen

Vermilion Short Shots: Technically vulnerable stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates. For a trial to Vermilion Research visit our website at www.vermilioncap.com or contact our sales team at (952) 922-7500.

Acushnet Holdings Corp: 1 director sold

A director at Acushnet Holdings Corp sold 20,000 shares at 35.640USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names ...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Signs Point To Healthy Pullback Opportunity The risk of a correction due to a “second wave” of infections has given way to optimism over increased monetary and fiscal stimulus and a potential COVID-19 steroid treatment. For now we view recent weakness as a countertrend move that helped correct the overbought conditions we noted last week. As long as the S&P 500 is above the 2940-2980 support zone we remain bullish and view this as a buyable pullback. · Major Indexes Remain Above Key Support Levels; Small- & Mid-Caps Still Outperforming. The S&P 500 has held above the big support...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Bulls Remain In Control It is hard to believe the market is within reach of its prior highs considering everything that has transpired this year: rioting/looting, a global pandemic, historic unemployment levels, and rising US-China tensions. The market is looking past these concerns in favor of the positives, namely: historic fiscal and monetary support, reopening the economy/flattening the curve, COVID-19 vaccine/treatment hopes, and low rates. As long as the breakouts that we highlighted last week (and again below) continue to hold, a bullish stance is appropriate. Below we highlight reason...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch